Castelo EL, Arnold DY, Trimiño FAA, de Armas RY

Language: Spanish
References: 24
Page: 250-256
PDF size: 99.95 Kb.

ABSTRACT

The metabolic syndrome (SM) is an assembly of associated conditions such as dislipidemia, arterial hypertension, intolerance to the glucose and obesity. At the beginning was described in 1988, and currently very is approved that is a matter of a situation of health that promotes the aterosclerosis. The Systems of Health of the diverse countries have increasing their interest in the SM, to the extent of recognizing it as a problem of Health Publishes, not alone by their high prevalence, but also by their role like factor of risk for the cardiovascular illnesses and the diabetes mellitus, that imply a great morbimortalidad. other illnesses that imply a great morbimortalidad. Multiple studies have been carried out to try to determine its prevalence in the population. They are put in practice regional programs of prevention of this syndrome, with the objective to achieve a decrease of the impact that the SM represents for the systems of health.

REFERENCES

1. Lozada M, Machado S, Manrique M, Martínez D, suárez O, Guevara H. Factores de riesgo asociados al síndrome metabólico en adolescentes. Gac Méd Caracas [Internet]. 2008 [citado 11 de agosto de 2009]116(4):323-9. Disponible en: http://www.scielo.org.ve/pdf/gmc/v116n4/art08.pdf

2. WHO. Definition, diagnosis and classifications of diabetes mellitus and its complications. Report of a WHO consultation. Genebra: WHO; 1999.

3. Eckel RH, Grundy SM, Zimmet PL. The metabolic syndrome. The Lancet. 2005;365(9468):1415-28.

4. Camerón AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am. 2004;33(2):35175.

5. Ford ES, Giles WH. A comparison of the prevalence of the metabolic síndrome using two proponed definitions. Diabetes Care. 2003;26(3):575-81.

6. Calderín Bouza RO, Yánez Quesada MA, Márquez Pérez I, Senra Piedra G, Denis de Armas R, Infante Amorós A, et al. Síndrome metabólico en familiares de primer grado de pacientes con diabetes mellitus tipo 2. Rev Cubana Endocrinol [Internet]. 2005 [citado 24 de septiembre de 2011];16(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532005000300003&lng=es

7. Cabalé MB, Sánchez D, Flores A. Prevalencia del síndrome metabólico en dislipidémicos. Rev Cubana Med [Internet]. 2006 [citado 24 de septiembre de 2011];45(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232006000300004&lng=es

8. Grundy SM. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes world. J Am Coll Cardiol. 2006;27(6):1093-100.

9. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607.

10. Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev. 1998;20(2):157-72.

11. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA [Internet]. 2002; [cited 2011 Sep 24]287(3):356-9. Available from: http://jama.ama-assn.org/content/287/3/356.full.pdf

12. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease. Am J Clin Nutr [Internet]. 1956 [cited 2009 Sep 30];4(1):20-34. Available from: http://www.ajcn.org/content/4/1/20.full.pdf+html

13. Vague J. La différenciation sexuelle, facteur déterminant des formes de l'obésité. Presse Med. 1947;30(3):339-40.

14. Avogaro P, Crepaldi G,Tiengo EA. Associazione di iperlipidemia, diabete mellito e obesità di medio grado. Acta Diabetol Lat. 1967;4(4):572-90.

15. Haller H. Epidemiologie und assocziierte Risikofaktoren der Hyperlipoproteinamie. Z Gesamte Inn Med [Internet]. 1977 [cited 2009 Sep 30]32(8):124-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/883354?dopt=Abstract

16. Phillips GB. Sex hormones, risk factors and cardiovascular disease. Am J Med. 1978;65(1):7-11.

17. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-607.

18. Burrows AR, Leiva BL, Weistaub G, Ceballos SX, Gattas ZV, Lera ML, et al . Síndrome metabólico en niños y adolescentes: asociación con sensibilidad insulínica y con magnitud y distribución de la obesidad. Rev Méd Chile [Internet]. 2007 [citado 24 de septiembre de 2011];135(2):174-81. Disponible en: http://www.scielo.cl/scielo.php?pid=S0034-98872007000200005&script=sci_arttext

19. Arce VM, Catalina PF, Mallo F, editores. Endocrinología. Santiago de Compostela, España: Servizo Publicacións USC. Servizo Publicacións U; 2006.

20. Koe Yountg T, Chateau D, Zhang M. Factor analysis of ethnic variation in the multiple metabolic (insulin resistance) syndrome in three Canadian populations. Am J Human Biol. 2002;14(5):649-58.

21. Weiss R, Darura J, Borgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350(23):2362-74.

22. Daniels SB, Amett DK, Eckel RH, Gidding SS, Hayman LL, Kumanyika S, et al. Overweight in children and adolescents: pathophysiology, consequences, prevention and treatment. Circulation [Internet]. 2005 [cited 2011 Sep 24];111(15):1999-2002. Available from: http://circ.ahajournals.org/content/111/15/1999.long

23. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA [Internet]. 2003 [cited 2011 Sep 24];287(3):356-9. Available from: http://jama.ama-assn.org/content/287/3/356.long

24. Álvarez León EE, Ribas Barba L, Serra Majem L. Prevalencia del síndrome metabólico en la población de la comunidad Canaria. Med Clin (Barc) 2003;120(5):172-4.